| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 05/07/2009 | CA2703915A1 P2x3 receptor antagonists for treatment of pain |
| 05/07/2009 | CA2703909A1 P2x3, receptor antagonists for treatment of pain |
| 05/07/2009 | CA2703825A1 New antibodies specific of the .beta.-amyloid peptides and their uses as diagnostic agents or drugs |
| 05/07/2009 | CA2703170A1 Composition |
| 05/07/2009 | CA2703063A1 Compositions for treating parkinson's disease |
| 05/07/2009 | CA2702134A1 Use of 3, 11b-cis-dihydrotetrabenazine in the treatment of multiple sclerosis and autoimmune myelitis |
| 05/07/2009 | CA2695628A1 Novel 6-triazolopyridazinesulfanyl benzothiazole and benzimidazole derivatives, method for production thereof and application as medicaments and pharmaceutical compositions and novel use as met inhibitors |
| 05/07/2009 | CA2690976A1 Benzenesulfonamide compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 05/06/2009 | EP2056111A1 Methods and compositions for regulating protein-protein interactions |
| 05/06/2009 | EP2055696A1 Acid addition salts of mandelic acid derivatives |
| 05/06/2009 | EP2055312A1 Molecular antigen array presenting amyloid beta |
| 05/06/2009 | EP2055301A1 Solid oral dosage forms comprising valsartan |
| 05/06/2009 | EP2054515A2 Use of a phage displaying a peptide from an adhesion protein for treating a disease associated with intracellular formation of protein fibrillar inclusions or aggregates |
| 05/06/2009 | EP2054419A2 Pyrimidinone derivatives and their use as a drug |
| 05/06/2009 | EP2054414A2 Imidazole amines as inhibitors of beta-secretase |
| 05/06/2009 | EP2054397A1 Small molecule inhibitors of kynurenine-3-monooxygenase |
| 05/06/2009 | EP2054390A1 Indazole derivatives that inhibit trpv1 and uses thereof |
| 05/06/2009 | EP2054374A1 Novel hydrate form of o-desmethyl venlafaxine succinate |
| 05/06/2009 | EP2054069A2 Use of a ginkgo biloba extract for the treatment of mitochondrial diseases of genetic origin |
| 05/06/2009 | EP2054062A1 Use of hppd inhibitors in the treatment of depression and/or withdrawal symptoms associated with addictive drugs |
| 05/06/2009 | EP2054060A1 Fluorinated ligands for targeting peripheral benzodiazepine receptors |
| 05/06/2009 | EP2054042A1 Methods for the preparation of biologically active compounds in nanoparticulate form |
| 05/06/2009 | EP2053919A2 Method of reducing neuronal cell damage |
| 05/06/2009 | EP1973907B1 Imidazo (1,2-a)pyridin-3-yl-acetic acid hydrazides, processes for their preparation and pharmaceutical uses thereof |
| 05/06/2009 | EP1945635B1 Thiazolyl piperidine derivatives useful as h3 receptor modulators |
| 05/06/2009 | EP1828199B1 Thieno-pyridine derivatives as gaba-b allosteric enhancers |
| 05/06/2009 | EP1783120B1 Method of obtaining 2-amino-6-alkyl-amino-4,5,6,7-tetrahydrobenzothiazoles |
| 05/06/2009 | EP1781686B1 Vla-4 antagonists |
| 05/06/2009 | EP1670757B1 Pyrrole and pyrazole derivatives as potentiators of glutamate receptors |
| 05/06/2009 | EP1581235B1 Use of spongosine (2-methoxyadenosein) for the treatment of pain, in particular hyperalgesia |
| 05/06/2009 | EP1521593B1 Transdermal botulinum toxin compositions |
| 05/06/2009 | EP1465861B1 Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors |
| 05/06/2009 | EP1458355B1 Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol |
| 05/06/2009 | EP1443961B1 Glycoprotein compositions |
| 05/06/2009 | EP1436264B9 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain |
| 05/06/2009 | EP1414525B1 2-(3,5-bis-trifluoromethyl-phenyl)-n-¬6-(1,1-dioxo-1.lambda.6-thiomorpholin-4-yl)-4-(2-methyl or 4-fluoro-2-methyl substituted)phenyl-pyridin-3-yl -n-methyl-isobutyramide |
| 05/06/2009 | EP1308440B1 Piperidine derivatives and drugs containing these derivatives as the active ingredient |
| 05/06/2009 | EP1268421B1 Phenyl-substituted indoles as histamine h3-receptor antagonists |
| 05/06/2009 | EP1244435B9 Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases |
| 05/06/2009 | EP1200114B1 Ppar delta inhibitors for the treatment of cardiovascular diseases |
| 05/06/2009 | EP1173155A4 Gum pad for delivery of medication to mucosal tissues |
| 05/06/2009 | EP1165114B1 Use of a lectin or conjugates for modulation of c-fibre activity |
| 05/06/2009 | EP1152750B1 Spontaneously dispersible n-benzoyl staurosporine compositions |
| 05/06/2009 | EP1089724B1 Cyano substituted oleanolic acid derivatives as no production inhibitors |
| 05/06/2009 | CN101426807A Neuroprotective compounds and uses thereof |
| 05/06/2009 | CN101426796A Meridamycin analogues for the treatment of neurodegenerativedisorders |
| 05/06/2009 | CN101426792A Pyrazolopyrimidines as therapeutic agents |
| 05/06/2009 | CN101426790A Novel 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives and their medical use |
| 05/06/2009 | CN101426778A N-substituted-azacyclylamines as histamine-3 antagonists |
| 05/06/2009 | CN101426763A Sulfide and disulfide compounds and compositions for cholesterol management and related uses |
| 05/06/2009 | CN101426753A Hydroxylated long-chain resveratrol derivatives useful as neurotrophic agents |
| 05/06/2009 | CN101426504A Powder composition comprising zaleplon of defined particle size distribution and pharmaceutical products made therefrom |
| 05/06/2009 | CN101426499A Modulators of muscarinic receptors |
| 05/06/2009 | CN101426494A Use of escitalopram for improving cognition |
| 05/06/2009 | CN101426483A Purine derivatives as A2A receptor agonists |
| 05/06/2009 | CN101426480A Utilization of inhibitors of rho-kinases for stimulating nerve growth, inhibiting scar tissue formation and/or reducing a secondary lesion |
| 05/06/2009 | CN101423500A Substituted benzoxazoles and analogues as estrogenic agents |
| 05/06/2009 | CN101423497A 6-amino-1H-indazole and 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors |
| 05/06/2009 | CN101423493A Aripiprazole anhydride crystal, method for producing the same and medicinal preparation containing the same |
| 05/06/2009 | CN101423492A Aripiprazole anhydride crystal, method for producing the same and medicinal preparation containing the same |
| 05/06/2009 | CN101422595A Traditional Chinese medicine composition for treating dizziness and preparation method and quality control method thereof |
| 05/06/2009 | CN101422589A Compound preparation capable of invigorating the brain and promoting intelligenc |
| 05/06/2009 | CN101422571A Psychosis positive four-step therapeutics series medicine |
| 05/06/2009 | CN101422523A Health-care preparation capable of alleviating a hangover and protecting the liver and preparation method thereof |
| 05/06/2009 | CN101422517A Traditional Chinese medicine composite capable of fighting against senium and reinforcing memory and preparation method thereof |
| 05/06/2009 | CN101422515A Chinese patent medicine |
| 05/06/2009 | CN101422499A Medicine composition for preventing the birth defect and improving the memory |
| 05/06/2009 | CN101422497A Ginsenoside Rb1 containing impurity Panax Notoginseng saponin R2 |
| 05/06/2009 | CN101422495A Comprehensive therapy method |
| 05/06/2009 | CN101422482A Medicine composition for preventing the birth defect and improving the memory |
| 05/06/2009 | CN101422460A Preparation method of FK506 slow-release film for repairing nerve damage |
| 05/06/2009 | CN101422447A Instant film preparation containing phenylephrine hydrochloride |
| 05/06/2009 | CN101422442A Levetiracetam osmotic pump controlled release tablet and preparation method thereof |
| 05/06/2009 | CN101422437A Etoposide dry suspension and preparation method thereof |
| 05/06/2009 | CN101422313A Tea-leaves pillow inner and production method thereof |
| 05/06/2009 | CN100486083C DC motor |
| 05/06/2009 | CN100484939C Polymorph forms of N-(2,3-dimethyl-5,6,7,8-tetrahydrofuro[2,3-b]quinolin-4-yl)-2-(2-oxopyrrolidin-1-yl) acetamide |
| 05/06/2009 | CN100484937C Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof |
| 05/06/2009 | CN100484934C Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinase |
| 05/06/2009 | CN100484933C Novel pyrazine compounds, their use in preparing medicament for treating diseases correlated with serotonin |
| 05/06/2009 | CN100484569C Medicament for mobilizing pluripotent stem cells from tissue into peripheral blood |
| 05/06/2009 | CN100484547C Ointment for neuroparalysis |
| 05/06/2009 | CN100484534C Application of marsilea in preparation of medicine for relieving alcoholism and hepatoprotection |
| 05/06/2009 | CN100484527C Sustained release formulation containing effective active component of galanthamin and its preparation process |
| 05/05/2009 | US7528265 Process for the preparation of simvastatin |
| 05/05/2009 | US7528252 Derivatives of triazoly-imidazopyridine useful as ligands of the adenosine A2a receptor and their use as medicaments |
| 05/05/2009 | US7528249 Amidating a cyclic carboxylic acid (methyl 1-[N-(3-methylbutyl)carbamoyl]cyclopentane-carboxylic acid) with an aminobenzodiazepinone (3-amino-1-methyl-5-phenyl-3H-benzoazepin-2-one) |
| 05/05/2009 | US7528233 covalent heterodimer of two different neurotrophins; which have multiple neurotrophic specificities; use in treatment of nervous system disorders |
| 05/05/2009 | US7528231 Kv10.1, a novel voltage-gated potassium channel from human brain |
| 05/05/2009 | US7528162 such as 3-(4-Chlorophenyl)-N'-((4-chlorophenyl)sulfonyl)-N-(piperidin-1-yl)-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboxamidine, used as cannabinoid (CB1) receptor antagonists, for prophylaxis of psychological disorders |
| 05/05/2009 | US7528156 Such as N-[2-(3-{[1-(3,4-dichlorobenzylpiperidinyl]aminohydroxypropoxy)phenyl]acetamide; antiinflammatory agents, antiarthritic agents; chronic obstructive pulmonary disease, asthma, multiple sclerosis |
| 05/05/2009 | US7528148 Pyrazolo[3,4-B]pyridine compounds, and their use as phosphodiesterase inhibitors |
| 05/05/2009 | US7528140 Substituted pyrrolo[3,2-d]pyrimidines as glycogen synthase kinase (GSK) inhibitors |
| 05/05/2009 | US7528129 CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions |
| 05/05/2009 | US7528127 Short-acting benzodiazepines |
| 05/05/2009 | US7528124 1,3-dihydro-2H-indol-2-one derivative |
| 05/05/2009 | US7528110 Anti-allergic complex molecules |
| 05/05/2009 | US7528093 Using genetic rearrangement in genomic region associated with brain voltage-gated sodium channel to detect convulsive disorder |
| 05/05/2009 | US7527974 Preparing embryonic stem cells via nuclear transplantation; tissue engineering and the use of embryonic stem in diagnosis, prevention and treatment of cell proliferative, nervous system, muscular and bone disorders; tissue repair |
| 05/05/2009 | US7527794 Nucleotide sequences coding immunoglobulin fusion specific to heparan sulfate proteoglycans for use as diagnostic and therapeutic tool in treatment and prevention of neurodegenerative and cell proliferative disorders |